A study to evaluate the prevalence of gut bacteria in stool of humans and poultry, and in drinking water sources, and compare their antibiotic response, thereby establishing the significance of the One Health concept
Not Applicable
- Conditions
- Health Condition 1: Z000- Encounter for general adult medical examination
- Registration Number
- CTRI/2024/07/071374
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Adults from community who have not received any known antibiotic for at least six months.
2. Adult patients admitted in Medicine wards / ICU who are currently on carbapenem therapy.
3. Fully grown broilers from commercial farms / markets
Exclusion Criteria
Individuals with any known gastro-intestinal illness.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms drive carbapenem resistance in Enterobacterales across human, poultry, and water ecosystems?
How do antibiotic resistance profiles of Klebsiella pneumoniae and Escherichia coli compare between human stool, poultry, and drinking water sources?
Which biomarkers in gut microbiota correlate with cross-species transmission of carbapenem-resistant Enterobacterales under One Health frameworks?
What adverse events are associated with zoonotic antibiotic-resistant bacteria exposure via contaminated water and poultry environments?
How do environmental reservoirs of carbapenem-resistant Enterobacterales influence antimicrobial stewardship strategies in human and veterinary medicine?